Utilization of optical coherence tomography as a noninvasive, bedside imaging technique to identify residual nodular basal cell carcinoma at a well-healed and clinically unidentifiable biopsy site

J Am Acad Dermatol. 2019 Jul;81(1):e9-e10. doi: 10.1016/j.jaad.2019.02.012. Epub 2019 Feb 13.

Authors

Hao Feng¹, Mitalee P Christman², Jon Holmes³, Roy G Geronemus²

Affiliations

¹ Laser and Skin Surgery Center of New York, New York, New York; The Ronald O. Perelman Department of Dermatology, New York University, New York, New York. Electronic address: haofeng625@gmail.com.
² Laser and Skin Surgery Center of New York, New York, New York; The Ronald O. Perelman Department of Dermatology, New York University, New York, New York.
³ Michelson Diagnostics Ltd, Maidstone, United Kingdom.

PMID: 30771419
DOI: 10.1016/j.jaad.2019.02.012

No abstract available

Keywords: OCT; bedside imaging; biopsy site identification; dermatologic surgery; optical coherence tomography; skin cancer; wrong site surgery.

MeSH terms

Carcinoma, Basal Cell / diagnostic imaging*
Carcinoma, Basal Cell / pathology
Carcinoma, Basal Cell / surgery
Humans
Nasolabial Fold
Neoplasm, Residual / diagnostic imaging*
Neoplasm, Residual / pathology
Neoplasm, Residual / surgery
Point-of-Care Testing*
Sensitivity and Specificity
Skin Neoplasms / diagnostic imaging*
Skin Neoplasms / pathology
Skin Neoplasms / surgery
Tomography, Optical Coherence / methods*